Massey becomes first U.S. site to enroll patients in global Phase 2a trial of first-in-class therapy for T-cell lymphoma

Media coverage

• Title	First-in-Class Therapy for T-Cell Lymphoma Enrolls Patients in New Clinical Trial
  Media name/outlet	MedIndia
  Country/Territory	India
  Date	07/27/25
  URL	https://www.medindia.net/news/first-in-class-therapy-for-t-cell-lymphoma-enrolls-patients-in-new-clinical-trial-220554-1.htm
  Persons	Robert A. Winn

• Title	VCU Massey pioneers clinical trial of novel GGT-1 inhibitor PTX-100
  Media name/outlet	News-Medical.Net
  Country/Territory	Australia
  Date	07/26/25
  URL	https://www.news-medical.net/news/20250726/VCU-Massey-pioneers-clinical-trial-of-novel-GGT-1-inhibitor-PTX-100.aspx
  Persons	Robert A. Winn

• Title	Massey becomes first U.S. site to enroll patients in global Phase 2a trial of first-in-class therapy for T-cell lymphoma
  Media name/outlet	EurekAlert!
  Country/Territory	United States
  Date	07/24/25
  URL	https://www.eurekalert.org/news-releases/1092447
  Persons	Robert A. Winn